• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低暴露地区肝癌中的黄曲霉毒素 B1-DNA 加合物。

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area.

机构信息

Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Cesare Maltoni Cancer Research Center, Ramazzini Institute, Via Saliceto 3, 40010 Bentivoglio, Italy.

出版信息

Nutrients. 2022 Apr 15;14(8):1652. doi: 10.3390/nu14081652.

DOI:10.3390/nu14081652
PMID:35458213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9024438/
Abstract

Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accumulating in the liver and possibly contributing to liver cancer. AFB1-DNA adducts were assayed by immunostaining in liver tissues from three Italian series of twenty cirrhosis without HCC, 131 HCC, and 45 cholangiocarcinoma, and in an AFB1-induced HCC rat model. CD68, TP53 immunostaining, and TP53 RFLP analysis of R249S transversion were used to characterize cell populations displaying AFB1-DNA adducts. Twenty-five HCCs displayed AFB1-adducts both in neoplastic hepatocytes and in cells infiltrating the tumor and non-tumor tissues. Nuclear immunostaining was observed in a few cases, while most cases showed cytoplasmic immunostaining, especially in CD68-positive tumor-infiltrating cells, suggestive for phagocytosis of dead hepatocytes. Similar patterns were observed in AFB1-induced rat HCC, though with higher intensity. Cholangiocarcinoma and cirrhosis without HCC did not displayAFB1-adducts, except for one case. Despite not providing a causal relationship with HCC, these findings still suggest paying attention to detection and control measures for aflatoxins to ensure food safety in low exposure areas.

摘要

黄曲霉毒素 B1(AFB1)是一种 1 类致癌物,已确定其在高暴露地区肝细胞癌(HCC)的发展中起作用。相反,本研究旨在检测在低暴露地区是否可能发生慢性/间歇性、低剂量 AFB1 摄入,这种摄入是否会在肝脏中蓄积,并可能导致肝癌。通过免疫染色法检测了来自三个意大利系列的 20 例无 HCC 肝硬化、131 例 HCC 和 45 例胆管癌的肝组织以及 AFB1 诱导的 HCC 大鼠模型中的 AFB1-DNA 加合物。CD68、TP53 免疫染色和 TP53 RFLP 分析用于鉴定显示 AFB1-DNA 加合物的细胞群。25 例 HCC 中均显示出 AFB1 加合物,这些加合物存在于肿瘤性肝细胞和浸润肿瘤及非肿瘤组织的细胞中。少数病例中观察到核免疫染色,而大多数病例显示细胞质免疫染色,尤其是在 CD68 阳性的肿瘤浸润细胞中,提示吞噬了死亡的肝细胞。在 AFB1 诱导的大鼠 HCC 中也观察到类似的模式,但强度更高。胆管癌和无 HCC 的肝硬化除了一例外均未显示 AFB1 加合物。尽管这些发现并未提供与 HCC 之间的因果关系,但仍建议在低暴露地区注意检测和控制黄曲霉毒素的措施,以确保食品安全。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f79/9024438/2f97918b0417/nutrients-14-01652-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f79/9024438/a85fc32f0711/nutrients-14-01652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f79/9024438/f8102560cd0e/nutrients-14-01652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f79/9024438/2f97918b0417/nutrients-14-01652-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f79/9024438/a85fc32f0711/nutrients-14-01652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f79/9024438/f8102560cd0e/nutrients-14-01652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f79/9024438/2f97918b0417/nutrients-14-01652-g003.jpg

相似文献

1
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area.低暴露地区肝癌中的黄曲霉毒素 B1-DNA 加合物。
Nutrients. 2022 Apr 15;14(8):1652. doi: 10.3390/nu14081652.
2
Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.尽管在日本南部地区,人们接触黄曲霉毒素 B1 的水平较低,但肝癌患者的肝内黄曲霉毒素 B1-DNA 加合物和 TP53 突变仍然存在。
Liver Int. 2011 Oct;31(9):1366-72. doi: 10.1111/j.1478-3231.2011.02572.x. Epub 2011 Jun 28.
3
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.台湾地区肝细胞癌中的p53突变、慢性乙型肝炎病毒感染及黄曲霉毒素暴露情况
Cancer Res. 1997 Aug 15;57(16):3471-7.
4
Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?黄曲霉毒素B1在美国肝细胞癌的病因学中起作用吗?
Nutr Cancer. 1999;35(1):27-33. doi: 10.1207/S1532791427-33.
5
Low-dose microcystin-LR antagonizes aflatoxin B1 induced hepatocarcinogenesis through decreasing cytochrome P450 1A2 expression and aflatoxin B1-DNA adduct generation.低剂量微囊藻毒素-LR 通过降低细胞色素 P450 1A2 表达和减少黄曲霉毒素 B1-DNA 加合物的生成来拮抗黄曲霉毒素 B1 诱导的肝癌发生。
Chemosphere. 2020 Jun;248:126036. doi: 10.1016/j.chemosphere.2020.126036. Epub 2020 Jan 25.
6
Aflatoxin B exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers.黄曲霉毒素B暴露会增加慢性乙型肝炎病毒携带者患肝硬化和肝细胞癌的风险。
Int J Cancer. 2017 Aug 15;141(4):711-720. doi: 10.1002/ijc.30782. Epub 2017 May 26.
7
Aflatoxin B exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption.黄曲霉毒素 B 暴露增加了与丙型肝炎病毒感染或酒精消费相关的肝细胞癌的风险。
Eur J Cancer. 2018 May;94:37-46. doi: 10.1016/j.ejca.2018.02.010. Epub 2018 Mar 20.
8
Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.健康男性的血浆抗氧化维生素、慢性乙型肝炎病毒感染与尿中黄曲霉毒素B1-DNA加合物
Carcinogenesis. 1997 Jun;18(6):1189-94. doi: 10.1093/carcin/18.6.1189.
9
Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods.黄曲霉毒素 B1:代谢、毒性、食品中存在、职业暴露和解毒方法综述。
Food Chem Toxicol. 2019 Feb;124:81-100. doi: 10.1016/j.fct.2018.11.047. Epub 2018 Nov 20.
10
Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cells.黄曲霉毒素 B1 暴露的肝癌患者的临床特征和黄曲霉毒素 B1 对肝癌细胞的分子机制。
Environ Toxicol Pharmacol. 2019 Oct;71:103225. doi: 10.1016/j.etap.2019.103225. Epub 2019 Jul 25.

引用本文的文献

1
Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma.黄曲霉毒素诱导的p53畸变与乙型肝炎病毒在肝细胞癌中的协同作用。
J Xenobiot. 2025 Jun 20;15(4):96. doi: 10.3390/jox15040096.
2
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.下一代抗病毒药物与肥胖流行时代的肝癌预防
Hepatology. 2025 Jan 14. doi: 10.1097/HEP.0000000000001227.
3
The Possible Role of Mycotoxins in the Pathogenesis of Endometrial Cancer.真菌毒素在子宫内膜癌发病机制中的可能作用。

本文引用的文献

1
Contamination by Aflatoxins B/G in Food and Commodities Imported in Southern Italy from 2017 to 2020: A Risk-Based Evaluation.2017年至2020年意大利南部进口食品和商品中黄曲霉毒素B/G的污染情况:基于风险的评估
Toxins (Basel). 2021 May 22;13(6):368. doi: 10.3390/toxins13060368.
2
Occupational Exposure to Mycotoxins-Different Sampling Strategies Telling a Common Story Regarding Occupational Studies Performed in Portugal (2012-2020).职业接触霉菌毒素——不同的采样策略讲述了 2012-2020 年在葡萄牙进行的职业研究的共同故事。
Toxins (Basel). 2020 Aug 11;12(8):513. doi: 10.3390/toxins12080513.
3
Application of the key characteristics of carcinogens in cancer hazard identification.
Toxins (Basel). 2024 May 23;16(6):236. doi: 10.3390/toxins16060236.
4
Mass Spectrometry-Based Method to Measure Aflatoxin B DNA Adducts in Formalin-Fixed Paraffin-Embedded Tissues.基于质谱法测定福尔马林固定石蜡包埋组织中黄曲霉毒素B DNA加合物
Chem Res Toxicol. 2024 Apr 15;37(4):633-642. doi: 10.1021/acs.chemrestox.4c00005. Epub 2024 Mar 18.
5
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research.肝细胞癌动物模型:在临床研究中的当前应用
J Hepatocell Carcinoma. 2022 Dec 8;9:1263-1278. doi: 10.2147/JHC.S347946. eCollection 2022.
6
May phytophenolics alleviate aflatoxins-induced health challenges? A holistic insight on current landscape and future prospects.植物酚类物质能缓解黄曲霉毒素引起的健康问题吗?对当前形势和未来前景的全面洞察。
Front Nutr. 2022 Oct 28;9:981984. doi: 10.3389/fnut.2022.981984. eCollection 2022.
致癌物关键特征在癌症危害识别中的应用。
Carcinogenesis. 2018 Apr 5;39(4):614-622. doi: 10.1093/carcin/bgy031.
4
Aflatoxin B exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption.黄曲霉毒素 B 暴露增加了与丙型肝炎病毒感染或酒精消费相关的肝细胞癌的风险。
Eur J Cancer. 2018 May;94:37-46. doi: 10.1016/j.ejca.2018.02.010. Epub 2018 Mar 20.
5
Aflatoxins: A Global Concern for Food Safety, Human Health and Their Management.黄曲霉毒素:食品安全、人类健康及其管理的全球关注问题。
Front Microbiol. 2017 Jan 17;7:2170. doi: 10.3389/fmicb.2016.02170. eCollection 2016.
6
Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis.免疫组织化学检测p53蛋白过表达以预测肝细胞癌中p53基因突变:一项荟萃分析
PLoS One. 2016 Jul 18;11(7):e0159636. doi: 10.1371/journal.pone.0159636. eCollection 2016.
7
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.在肝细胞癌中,miR-519d 受 p53 和 DNA 低甲基化的上调,并靶向 CDKN1A/p21、PTEN、AKT3 和 TIMP2。
J Pathol. 2012 Jul;227(3):275-85. doi: 10.1002/path.3995. Epub 2012 Apr 18.
8
Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.尽管在日本南部地区,人们接触黄曲霉毒素 B1 的水平较低,但肝癌患者的肝内黄曲霉毒素 B1-DNA 加合物和 TP53 突变仍然存在。
Liver Int. 2011 Oct;31(9):1366-72. doi: 10.1111/j.1478-3231.2011.02572.x. Epub 2011 Jun 28.
9
Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.黄曲霉毒素诱发肝细胞癌的全球负担:一项风险评估。
Environ Health Perspect. 2010 Jun;118(6):818-24. doi: 10.1289/ehp.0901388. Epub 2010 Feb 19.
10
Mycotoxins and human disease: a largely ignored global health issue.真菌毒素与人类疾病:一个被严重忽视的全球健康问题。
Carcinogenesis. 2010 Jan;31(1):71-82. doi: 10.1093/carcin/bgp264. Epub 2009 Oct 29.